bf/AMEX:LCTX_icon.png

COM:LINEAGECELL

Lineage Cell Therapeutics, Inc.

  • Stock

USD

Last Close

0.60

22/11 21:00

Market Cap

180.52M

Beta: -

Volume Today

2.48K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
117.00K
-
222.36K
90.04%
133.51K
39.96%
500
99.63%
0.50
-
average payables
3.94M
-
5.35M
35.71%
4.80M
10.19%
4.97M
3.55%
4.04M
18.71%
3.70M
8.43%
5.84M
57.94%
3.92M
32.95%
3.08M
21.48%
2.97M
3.54%
2.22M
25.15%
average receivables
709.92K
-
1.53M
115.86%
1.40M
8.58%
2.10M
50%
3.38M
60.96%
13.83M
308.85%
11.97M
13.43%
25.42M
112.35%
25.57M
0.58%
521K
97.96%
book value per share
0.27
-
0.55
100.95%
0.34
38.49%
1.21
259.21%
1.42
17.24%
0.74
47.95%
0.78
4.96%
0.64
17.40%
0.56
12.56%
0.43
22.95%
0.37
14.96%
capex per share
-0.04
-
-0.01
82.69%
-0.07
820.67%
-0.03
61.21%
-0.01
55.37%
-0.03
123.61%
-0.00
88.33%
-0.00
85.89%
-0.00
404.51%
-0.00
13.03%
-0.00
60.48%
capex to depreciation
-0.58
-
-0.06
90.03%
-0.84
1,366.07%
-0.53
36.94%
-0.40
24.24%
-1.00
149.63%
-0.15
85.40%
-0.03
78.60%
-0.41
1,191.89%
-0.57
40.10%
-0.97
71.45%
capex to operating cash flow
0.08
-
0.01
83.89%
0.12
863.09%
0.06
50.16%
0.04
27.19%
0.11
144.96%
0.01
87.06%
0.00
76.48%
0.02
363.73%
-0.39
2,695.64%
0.02
106.05%
capex to revenue
-0.80
-
-0.25
68.82%
-2.10
748.08%
-1.12
46.71%
-0.74
34.03%
-2.32
213.71%
-0.30
87.18%
-0.08
72.19%
-0.09
9.74%
-0.03
69.09%
-0.08
168.25%
cash per share
0.10
-
0.44
337.75%
0.54
21.55%
0.23
56.71%
0.33
42.87%
0.24
27.36%
0.21
12.87%
0.28
31.24%
0.35
28.07%
0.34
3.92%
0.21
39.69%
days of inventory on hand
82.28
-
116.00
40.97%
0.33
99.72%
days payables outstanding
1.79K
-
2.97K
65.70%
922.56
68.90%
7.28K
689.51%
2.04K
72.02%
7.81K
283.30%
4.63K
40.73%
2.48K
46.53%
906.87
63.36%
1.20K
32.30%
548.97
54.24%
days sales outstanding
266.26
-
236.95
11.01%
187.52
20.86%
620.42
230.85%
958.64
54.52%
5.91K
516.72%
1.89
99.97%
4.76K
252,077.36%
7.37
99.85%
30.40
312.31%
debt to assets
0.01
-
0.05
666.18%
0.03
48.19%
0.01
68.32%
0.02
151.78%
0.04
84.86%
0.03
25.73%
0.02
47.52%
0.03
96.25%
0.03
7.24%
debt to equity
0.01
-
0.19
1,212.71%
0.03
82.21%
0.01
72.09%
0.02
156.08%
0.05
89.55%
0.03
24.98%
0.03
11.48%
0.05
74.84%
0.05
12.38%
dividend yield
0.00
-
0.30
16,053.10%
0.00
99.90%
0.10
30,735.17%
0.02
81.14%
0.00
-
earnings yield
-0.22
-
-0.15
34.67%
-0.14
2.10%
0.10
166.46%
-0.08
184.93%
-0.40
390.68%
-0.09
77.07%
-0.08
14.22%
-0.10
22.16%
-0.13
38.64%
-0.11
13.94%
enterprise value
189.72M
-
218.96M
15.41%
289.69M
32.30%
333.20M
15.02%
210.82M
36.73%
94.16M
55.34%
125.20M
32.96%
234.79M
87.54%
350.09M
49.10%
191.20M
45.39%
155.71M
18.56%
enterprise value over ebitda
-11.08
-
-4.32
61.01%
-4.59
6.13%
-2.34
48.97%
-3.91
66.91%
-2.93
25.12%
-2.31
21.18%
-9.39
307.15%
-6.63
29.36%
-9.64
45.44%
-6.48
32.84%
ev to operating cash flow
-6.43
-
-5.64
12.35%
-6.50
15.40%
-7.87
21.05%
-6.91
12.25%
-3.05
55.86%
-3.92
28.53%
-11.89
203.32%
-14.86
25.01%
180.55
1,315.07%
-5.45
103.02%
ev to sales
66.31
-
112.50
69.65%
114.32
1.62%
147.96
29.42%
117.64
20.49%
66.50
43.48%
84.71
27.38%
303.74
258.59%
89.86
70.42%
13.00
85.53%
17.41
33.86%
free cash flow per share
-0.59
-
-0.59
0.97%
-0.63
5.73%
-0.46
26.34%
-0.28
39.65%
-0.27
3.20%
-0.22
17.35%
-0.13
40.65%
-0.15
10.07%
0.00
102.62%
-0.17
4,551.05%
free cash flow yield
-0.16
-
-0.16
2.55%
-0.15
3.81%
-0.13
16.35%
-0.13
1.34%
-0.30
128.70%
-0.25
15.49%
-0.08
69.99%
-0.06
20.93%
0.00
105.48%
-0.16
4,877.74%
graham net net
-0.18
-
0.28
252.78%
0.33
17.16%
0.12
63.72%
0.28
132.34%
0.19
30.90%
0.24
24.53%
0.19
19.05%
0.08
59.25%
0.04
51.94%
-0.02
145.47%
graham number
2.23
-
2.60
16.63%
2.12
18.64%
3.07
44.98%
2.36
22.99%
2.46
3.97%
1.19
51.48%
1.41
18.37%
1.72
21.94%
1.23
28.58%
1.01
17.43%
income quality
0.56
-
0.89
59.13%
0.77
13.66%
-2.27
396.65%
1.31
157.65%
0.66
49.62%
2.70
309.21%
0.95
64.65%
0.54
42.98%
-0.04
107.38%
1.33
3,408.48%
intangibles to total assets
0.80
-
0.52
35.20%
0.35
31.58%
0.07
79.83%
0.04
44.36%
0.03
22.82%
0.47
1,427.55%
0.53
13.84%
0.33
38.38%
0.46
40.83%
0.57
22.14%
interest coverage
-2.15
-
7.36
442.99%
3.66
50.31%
0.76
79.22%
2.24
194.74%
-3.84
271.62%
-23.07
500.16%
-4.35
-
interest debt per share
0.48
-
-0.10
119.89%
-0.16
69.05%
-0.76
367.62%
-0.14
81.71%
0.10
174.84%
0.05
54.51%
0.02
53.27%
0.02
22.60%
0.05
213.85%
0.02
68.02%
inventory turnover
4.44
-
3.15
29.07%
1.11K
35,081.37%
invested capital
0.01
-
0.19
1,212.71%
0.03
82.21%
0.01
72.09%
0.02
156.08%
0.05
89.55%
0.03
24.98%
0.03
11.48%
0.05
74.84%
0.05
12.38%
market cap
195.21M
-
247.92M
27.00%
326.82M
31.82%
351.31M
7.50%
246.12M
29.94%
115.48M
53.08%
129.52M
12.16%
264.08M
103.88%
403.03M
52.62%
198.66M
50.71%
188.20M
5.26%
net current asset value
-7.52M
-
20.23M
369.06%
29.02M
43.50%
13.59M
53.19%
33.65M
147.66%
26.94M
19.92%
43.29M
60.66%
31.18M
27.98%
27.90M
10.50%
8.27M
70.35%
-555K
106.71%
net debt to ebitda
0.32
-
0.57
78.04%
0.59
2.84%
0.13
78.36%
0.65
414.40%
0.66
1.25%
0.08
87.96%
1.17
1,368.55%
1.00
14.34%
0.38
62.48%
1.35
259.18%
net income per share
-0.81
-
-0.55
32.31%
-0.59
7.61%
0.34
158.52%
-0.17
150.58%
-0.36
107.68%
-0.08
77.58%
-0.14
69.64%
-0.23
70.05%
-0.16
33.79%
-0.12
19.82%
operating cash flow per share
-0.54
-
-0.58
7.42%
-0.56
4.40%
-0.43
22.17%
-0.27
38.71%
-0.24
8.71%
-0.22
9.79%
-0.13
40.03%
-0.14
8.79%
0.01
104.35%
-0.17
2,752.60%
payables turnover
0.20
-
0.12
39.65%
0.40
221.56%
0.05
87.33%
0.18
257.41%
0.05
73.91%
0.08
68.72%
0.15
87.04%
0.40
172.96%
0.30
24.41%
0.66
118.55%
receivables turnover
1.37
-
1.54
12.37%
1.95
26.36%
0.59
69.77%
0.38
35.28%
0.06
83.79%
193.25
312,917.93%
0.08
99.96%
49.51
64,500.53%
12.01
75.75%
research and ddevelopement to revenue
9.30
-
19.28
107.33%
16.81
12.81%
16.03
4.64%
13.41
16.38%
14.80
10.39%
12.14
17.94%
15.93
31.22%
8.70
45.37%
0.95
89.07%
1.74
83.03%
return on tangible assets
-3.81
-
-1.01
73.48%
-0.77
23.81%
0.25
132.96%
-0.12
147.35%
-0.47
288.65%
-0.18
61.93%
-0.41
131.68%
-0.33
19.97%
-0.40
20.65%
-0.49
23.46%
revenue per share
0.05
-
0.03
44.50%
0.03
8.56%
0.02
27.21%
0.02
32.35%
0.01
28.72%
0.01
8.98%
0.01
49.27%
0.02
359.71%
0.09
265.63%
0.05
40.17%
roe
-2.96
-
-1.00
66.31%
-1.75
74.96%
0.28
116.29%
-0.12
143.14%
-0.49
299.02%
-0.10
78.64%
-0.22
105.37%
-0.42
94.48%
-0.36
14.07%
-0.34
5.72%
roic
-3.56
-
-1.16
67.48%
-1.67
44.61%
-4.98
197.12%
0.14
102.84%
-0.42
398.73%
-0.19
54.06%
-0.24
25.19%
-0.45
84.71%
-0.28
36.79%
-0.33
17.64%
sales general and administrative to revenue
5.44
-
9.02
65.86%
11.50
27.47%
12.62
9.79%
11.12
11.93%
17.46
57.07%
16.26
6.89%
20.14
23.89%
4.67
76.79%
1.53
67.25%
1.93
26.35%
shareholders equity per share
0.27
-
0.55
100.95%
0.34
38.49%
1.21
259.21%
1.42
17.24%
0.74
47.95%
0.78
4.96%
0.64
17.40%
0.56
12.56%
0.43
22.95%
0.37
14.96%
stock based compensation to revenue
1.12
-
2.29
103.52%
4.36
90.50%
3.53
19.03%
2.19
37.85%
3.81
73.87%
2.42
36.51%
2.88
18.94%
0.90
68.65%
0.29
67.72%
0.52
77.91%
tangible asset value
-3.95M
-
23.87M
705.06%
42.85M
79.50%
120.30M
180.72%
157.36M
30.81%
89.12M
43.37%
52.33M
41.29%
37.42M
28.48%
33.40M
10.74%
14.57M
56.38%
4.79M
67.14%
tangible book value per share
-0.07
-
0.36
593.63%
0.54
49.68%
1.24
129.94%
1.37
11.20%
0.70
48.91%
0.36
48.80%
0.25
30.63%
0.20
18.58%
0.09
57.74%
0.03
67.68%
working capital
992.07K
-
25.28M
2,447.73%
34.77M
37.58%
16.80M
51.69%
35.74M
112.77%
29.55M
17.34%
51.02M
72.70%
36.23M
29.00%
64.43M
77.84%
41.02M
36.34%
20.48M
50.07%

All numbers in USD (except ratios and percentages)